Several INFN Sections and Departments of Physics of Italian Universities have spent many man-years in the attempt to adapt detector and read-out technologies, originally developed in the field of High Energy Physics, to the domain of biomedical apparatuses.
Personnel deployments abroad have skyrocketed, too, from 4,900 "man-years" in 2001 to 11,500 in 2013.
The age-standardised rates increased from 32/100 000 men-years in 1971 to 89/100 000 men-years in 2000, an almost threefold increase.
The crude incidence of registered prostate cancer was 360 out of 100 000 men-years in men who had a PSA test before diagnosis, and 248 out of 100 000 men-years in men with no prediagnosis PSA test.
The men-years in the tested category rose from 0.6% at age 40 44 years to 72% at age 85 89 years.
Adjusted CVD death rates (per 1,000 man-years) in men aged ≥50 years with neither, metabolic syndrome only, diabetes only, and both were 4.8, 8.0, 12.9, and 14.8, respectively.
They were characterised by a strong incidence gradient, with rates increasing from 5.6 to 8.2 per 100,000 man-years in Cyprus and the Nordic countries (Sweden, Finland, Norway and Iceland) up to 27.0-33.0 per 100,000 man-years in Spain, the Slovak Republic and France.
In Southeast England the age-standardised incidence rates in men increased from 0.79 per 100,000 man-years in 1960-1964 to 1.06 in 2000-2004.
Age-standardised rates of anal cancer ranged from 0.2 (in Cyprus, Finland and Iceland) to 0.7 per 100,000 man-years (in the United Kingdom) (CI5 Volume IX).
Age-, examination year–, and smoking-adjusted CVD death rates (per 1,000 man-years) in men with neither metabolic syndrome nor diabetes, metabolic syndrome only, diabetes only, and both were 1.9, 3.3, 5.5, and 6.5, respectively.
